Vyzulta is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is Latanoprostene Bunod.
Product ID | 24208-504_06204573-97d3-4253-8685-87273ea08d58 |
NDC | 24208-504 |
Product Type | Human Prescription Drug |
Proprietary Name | Vyzulta |
Generic Name | Latanoprostene Bunod |
Dosage Form | Solution/ Drops |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 2017-11-02 |
Marketing Category | NDA / NDA |
Application Number | NDA207795 |
Labeler Name | Bausch & Lomb Incorporated |
Substance Name | LATANOPROSTENE BUNOD |
Active Ingredient Strength | 0 mg/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-06-11 |
NDC Exclude Flag | N |
Sample Package? | Y |
Marketing Category | NDA |
Application Number | NDA207795 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2017-11-02 |
Marketing Category | NDA |
Application Number | NDA207795 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2018-06-11 |
Marketing Category | NDA |
Application Number | NDA207795 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-06-11 |
Marketing Category | NDA |
Application Number | NDA207795 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2017-11-02 |
Ingredient | Strength |
---|---|
LATANOPROSTENE BUNOD | .24 mg/mL |
SPL SET ID: | 60ce7900-a677-4fc2-88d0-1603baa9dbd4 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VYZULTA 87474310 not registered Dead/Abandoned |
Bausch & Lomb Incorporated 2017-06-04 |
VYZULTA 87473150 5525995 Live/Registered |
Bausch & Lomb Incorporated 2017-06-02 |
VYZULTA 86111055 not registered Dead/Abandoned |
Bausch & Lomb Incorporated 2013-11-05 |